U.S. judge schedules 2019 trial in opioid litigation

(Reuters) – A federal judge pushing for a settlement in lawsuits seeking to hold drug companies responsible for their roles in the U.S. opioid epidemic on Wednesday set an aggressive schedule that would have the first trial take place in March 2019.


Source: Reuters Medical News

U.S. FDA approves AI device to detect diabetic eye disease

(Reuters) – U.S. health regulators said on Wednesday it will allow sale of the first medical device that uses artificial intelligence (AI) software to detect greater than a mild level of the most common cause of vision loss among more than 30 million Americans living with diabetes.


Source: Reuters Medical News